​

Corcept Therapeutics Ownership | Who Owns Corcept Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Corcept Therapeutics Ownership Summary


Corcept Therapeutics is owned by 76.05% institutional investors, 11.32% insiders, and 12.62% retail investors. Blackrock is the largest institutional shareholder, holding 16.09% of CORT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.38% of its assets in Corcept Therapeutics shares.

CORT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCorcept Therapeutics76.05%11.32%12.62%
SectorHealthcare Stocks 129.40%12.08%-41.48%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock16.54M16.09%$537.36M
Blackrock funding, inc. /de10.20M9.67%$1.17B
Vanguard group9.49M9.17%$330.42M
Ingalls & snyder7.67M7.28%$883.56M
Renaissance4.85M4.60%$558.88M
Vanguard portfolio management4.78M4.53%$550.46M
Vanguard capital management4.35M4.13%$501.64M
Parallel advisors3.90M3.70%$449.69M
Fmr3.49M3.31%$402.01M
State street3.10M2.95%$357.78M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ingalls & snyder7.67M22.58%$883.56M
Tanaka capital management111.21K16.64%$9.24M
Checkpoint capital392.33K10.92%$32.61M
Parallel advisors3.90M6.06%$449.69M
Tang capital management1.50M5.92%$130.43M
Propel bio management75.27K4.60%$8.67M
Bioimpact capital771.03K4.09%$67.04M
Birchview capital, lp55.20K3.67%$6.36M
Lisanti capital growth89.35K2.76%$10.30M
Emerald advisers758.26K2.40%$87.37M

Top Buyers

HolderShares% AssetsChange
Aqr capital management2.58M0.08%2.18M
Jane street group763.54K0.01%757.07K
Jacobs levy equity management695.53K0.22%695.53K
Norges bank487.06K0.00%487.06K
Federated hermes421.74K0.07%421.74K

Top Sellers

HolderShares% AssetsChange
Novo---2.41M
Blackrock funding, inc. /de10.20M0.02%-2.24M
Sixth street partners management company---1.16M
Td asset management---994.84K
Ikarian capital---994.50K

New Positions

HolderShares% AssetsChangeValue
Jacobs levy equity management695.53K0.22%695.53K$60.48M
Norges bank487.06K0.00%487.06K$42.35M
Tanaka capital management111.21K16.64%111.21K$9.24M
Qube research100.75K0.01%100.75K$11.61M
Retirement systems of alabama98.12K0.03%98.12K$11.31M

Sold Out

HolderChange
Dunhill financial-1.00
Tortoise investment management-1.00
Tfc financial management-1.00
Western wealth management-2.00
Annis gardner whiting capital advisors-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202652616.63%80,143,547-4.05%761.21%2966.09%15132.46%
Jun 30, 202644620.87%83,266,7454.66%791.36%27753.04%110-14.73%
Mar 31, 2026178-57.31%22,402,023-70.75%210.39%71-61.41%72-54.43%
Dec 31, 2025281-37.56%56,456,655-26.85%540.99%115-47.25%111-24.49%
Sep 30, 2025427-0.93%76,942,4182.16%731.41%209-5.86%137-9.87%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.82M5.38%-2.31K
iShares Core S&P Mid-Cap ETF3.42M3.16%1.84K
Vanguard MStar Total Stk Mkt Idx Invest3.09M2.86%191.11K
Vanguard Total Stock Mkt Idx Inv2.89M2.70%11.26K
Vanguard US Total Market Shares ETF2.83M2.68%213.93K
Vanguard Morn Total Stk Mkt Idx Investor2.89M2.68%11.26K
Vanguard Small Cap Index2.19M2.03%90.59K
iShares Russell 2000 ETF2.03M1.91%-
Fidelity Contrafund1.53M1.41%63.05K
Vanguard MStar Small Cap Growth Indx Inv1.22M1.13%12.64K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 13, 2026WILSON JAMES N-Sell$1.86K
Nov 13, 2026WILSON JAMES N-Sell$41.34K
Nov 13, 2026WILSON JAMES N-Sell$526.17K
Nov 13, 2026WILSON JAMES N-Sell$157.32K
Nov 10, 2026Swisher Daniel N JR-Sell$111.11K

Insider Transactions Trends


DateBuySell
2026 Q4-17
2026 Q3-60
2026 Q2-18
2026 Q125
2025 Q4-26

CORT Ownership FAQ


Who owns the most shares of Corcept Therapeutics?

Corcept Therapeutics’s largest shareholders are Blackrock (16.54M shares, 16.09%), Blackrock funding, inc. /de (10.2M shares, 9.67%), and Vanguard group (9.49M shares, 9.17%). Together, they hold 34.93% of Corcept Therapeutics’s total shares outstanding.

Does Blackrock own Corcept Therapeutics?

Yes, BlackRock owns 16.09% of Corcept Therapeutics, totaling 16.54M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 537.36M$. In the last quarter, BlackRock decreased its holdings by -287K shares, a -1.71% change.

Who is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested?

Ingalls & snyder is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested, with 22.58% of its assets in 7.67M Corcept Therapeutics shares, valued at 883.56M$.

Who is the top mutual fund holder of Corcept Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Corcept Therapeutics shares, with 5.38% of its total shares outstanding invested in 5.82M Corcept Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools